Phase III VERITAC-2 trial results show vepdegestrant significantly improved progression-free survivalcompared to fulvestrant ...

We recently published a list of 14 Best Affordable Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Pfizer is paying $650 million in upfront cash and making a $350 million equity investment in Arvinas, with another $1.4 billion in backloaded milestone payments.

The approach has become a hot topic in biopharma with a string of big ticket partnerships over the last couple of years, including a $2.4 billion alliance between Pfizer and Arvinas for a breast ...